Blood Tests in Decompensated Cirrhosis: Bilirubin, INR, Sodium, Creatinine, and What Changes Mean

TL;DR

• Blood tests help clinicians understand liver function, kidney function, fluid balance, and short-term risk in decompensated cirrhosis.
• Bilirubin, INR, creatinine, sodium and albumin are also used in prognostic tools such as MELD 3.0.
• A single abnormal result rarely tells the whole story. Trends and symptoms matter more than one isolated number.
• Ammonia levels do not reliably match the severity of hepatic encephalopathy. HE is primarily a clinical diagnosis.
• Patients in mama health conversations rarely talked about laboratory values themselves. They were more likely to notice the treatment changes those results triggered.

Why are blood tests important in decompensated cirrhosis?

Blood tests help clinicians understand how the liver, kidneys, circulation, and treatments are interacting.

Yet patients do not always know what the numbers mean.

Among mama health's Italian patient conversations, only a handful contained enough discussion of specific blood-test results to analyse in depth — routine testing is likely far more common than these conversations suggest, patients just don't tend to talk about it in those terms.

The gap is revealing: patients often experience the consequences of a result — a changed diuretic dose, another test, hospital admission — without understanding why the number mattered.

What does bilirubin mean in cirrhosis?

Bilirubin helps show how effectively the liver is processing and excreting a substance produced when red blood cells are broken down.

When bilirubin accumulates, the skin and whites of the eyes can become yellow. This is jaundice.

Among the detailed patient conversations mama health could draw on, bilirubin was the laboratory value carrying the most emotional weight because patients could also see its effects in the mirror.

A rising bilirubin can occur when liver function worsens, but bilirubin can change for other reasons too. Clinicians therefore interpret it alongside other laboratory results, symptoms, imaging, medications, and the person's overall condition.

Bilirubin is also one of the variables used in MELD calculations.

What does INR mean in decompensated cirrhosis?

INR can provide information about the liver's ability to produce certain proteins involved in blood clotting.

An increasing INR can accompany worsening liver synthetic function and is included in the MELD score.

But there is an important misconception: a high INR in cirrhosis does not automatically mean someone will bleed.

Cirrhosis affects proteins that promote clotting and proteins that prevent clotting. Because INR measures only part of this system, AASLD advises that INR alone is not a reliable measure of bleeding risk in cirrhosis.

This is why clinicians interpret INR differently in cirrhosis than they would in someone taking warfarin.

What does sodium mean in cirrhosis?

Low blood sodium in advanced cirrhosis often reflects problems with water balance and circulation rather than simply not eating enough salt.

Portal hypertension and changes in circulation can cause the body to retain water. This can dilute the sodium in the bloodstream.

Low sodium — called hyponatremia — is particularly common in people with cirrhosis and ascites. It can also be affected by diuretics, diarrhoea, dehydration, bleeding, infection, and other changes in fluid balance.

Sodium matters because lower levels are associated with more advanced circulatory dysfunction and poorer outcomes. This is why sodium became part of MELD-based prognostic assessment.

Patients should not respond to a low sodium result by changing salt or fluid intake without discussing it with their healthcare team.

What does creatinine mean?

Creatinine is mainly used to assess kidney function, which can become especially important once cirrhosis decompensates.

The liver and kidneys are closely connected in advanced cirrhosis.

A rising creatinine may indicate that kidney function is worsening. Possible contributors can include dehydration, infection, medications, changes in circulation, or complications such as hepatorenal syndrome.

Creatinine also influences MELD because kidney dysfunction significantly affects prognosis in advanced liver disease.

This helps explain something patients described to mama health: their diuretic doses sometimes changed after routine blood tests even though they did not know which laboratory result had triggered the adjustment.

Clinicians often assess creatinine, sodium, potassium, blood pressure and symptoms together when reviewing diuretic treatment.

Why can someone have hepatic encephalopathy with a normal ammonia level?

Ammonia levels do not reliably match how severe hepatic encephalopathy is.

This was one of the clearest areas of confusion in what patients told mama health.

A caregiver may see severe confusion or personality changes while being told that the ammonia result is not particularly high.

That can seem contradictory, but hepatic encephalopathy is more complicated than one laboratory number.

AASLD states that increased ammonia alone does not provide reliable diagnostic or staging information for hepatic encephalopathy. People across different HE grades can have overlapping ammonia levels, and improvement in cognition does not always match changes in ammonia.

Hepatic encephalopathy is therefore primarily diagnosed clinically.

A normal ammonia result may prompt clinicians to reconsider other possible causes of confusion, but it should not be interpreted by patients as proof that their symptoms are unimportant.

What about albumin and platelets?

Albumin and platelet counts can provide additional information, but neither should be interpreted alone.

Albumin is produced by the liver. Low albumin can occur with reduced liver synthetic function, but inflammation, malnutrition, kidney disease and fluid overload can also lower it.

Albumin is now included in MELD 3.0 calculations alongside bilirubin, sodium, INR and creatinine.

Low platelet counts are also common in cirrhosis, particularly with portal hypertension and an enlarged spleen.

Like INR, however, the platelet count alone does not fully predict bleeding risk.

Does one abnormal blood test mean cirrhosis is getting worse?

Not necessarily. Clinicians usually look at the direction of several results over time rather than judging the disease from one result.

Blood tests can change because of infection, dehydration, bleeding, medications, diuretic treatment, kidney problems, fluid shifts after procedures, or changes in liver function.

A change from a person's usual baseline may sometimes be more informative than whether a single result falls outside the laboratory's "normal" range.

This is why laboratory trends are so important in decompensated cirrhosis.

How do blood tests affect MELD?

MELD combines several laboratory measurements to estimate short-term medical risk and help inform liver transplant prioritisation.

Current MELD 3.0 calculations incorporate bilirubin, INR, creatinine, sodium and albumin, alongside additional factors in the formula.

The individual values therefore contribute to a broader picture.

A MELD score should not be understood as a personal countdown. It is one clinical tool among several used alongside complications, functional status and transplant assessment. mama health's guide to decompensated cirrhosis life expectancy goes into more detail on how MELD and Child-Pugh relate to prognosis.

What can patients monitor between blood tests?

Simple observations at home can complement — not replace — laboratory monitoring.

For people with ascites, AASLD includes daily weight monitoring as part of outpatient management.

Depending on instructions from their healthcare team, patients may also find it useful to notice changes in abdominal swelling, leg or ankle swelling, weight, concentration or unusual confusion, bowel movements when using lactulose, appetite and ability to eat, urine output, and overall strength and mobility.

There is no universal weight or swelling threshold that applies to every patient. A healthcare team can explain which changes matter for an individual's situation and when they would want to be contacted.

What should patients ask about their blood results?

Patients can ask clinicians to translate laboratory values into what they mean for the current treatment plan.

Useful questions include:

• Which results are you watching most closely?
• Is this value changing compared with my previous tests?
• Is my kidney function stable?
• Are my sodium levels affecting my treatment?
• Why has my diuretic dose changed?
• How do these results affect my MELD score?
• Which changes would make you want to repeat my blood tests?
• If I become confused despite a normal ammonia result, what should my caregiver do?

The goal is not to interpret laboratory results independently. It is to make the reasoning behind medical decisions easier to understand.

What is the main thing to remember about cirrhosis blood tests?

Blood tests are pieces of a larger clinical picture, not verdicts on their own.

Bilirubin helps describe bilirubin handling and liver dysfunction. INR contributes information about liver synthetic function but does not independently predict bleeding. Sodium reflects important changes in fluid and circulatory balance. Creatinine shows how the kidneys are coping. And ammonia is a reminder that the number on the page does not always match what a patient or caregiver can see.

For patients, understanding why these tests are being followed may make the monitoring process less opaque — and make conversations about treatment, prognosis and transplant evaluation easier to follow.

Disclaimer: This content is informational and not a medical device. mama health offers information and support and does not replace a doctor.